The Office of Medicaid Fraud and Abuse Control announced today that Kentucky will intervene in a civil lawsuit against Healthpoint.
Kentucky is one of 13 states that moved to join the lawsuit claiming that Healthpoint caused Medicaid to pay $90 million in claims for the drug xenaderm, despite the drug's ineligibility for coverage.
The complaint further alleges that Healthpoint actively marketed xenaderm to nursing homes as a medicaid-eligible drug.
Attorney General Jack Conway said he was pleased that the motion to intervene in the lawsuit was granted.